In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biopharma Quarterly Dealmaking Statistics, Q3 2018

A look at financing, M&A and alliance activity July-September 2018

Executive Summary

Biopharma financing reached $14.6 billion in the third quarter, a 15% increase over Q2, while merger and acquisitions, at $7.7 billion (the lowest quarter of the year so far), showed a sharp decline. Alliance value reached $20.3 billion, far exceeding the $13.8 billion from Q2.

Advertisement

Related Content

Just What We Were Looking For: Roche Pays €70m For Preclinical Anti-CD25 Asset
Alexion Continues Pipeline Rebuilding With $400m Takeout Of Syntimmune
Novartis Blows Storm Clouds Off Sandoz US In Aurobindo Sale
Bluebird Casts Wide Partnering Net To Keep Advancing Cell Therapy
Roche Pact Is Affirmation Of Affimed Technology
GBT Picks Up Inclacumab From Roche's Bargain Bin
Perrigo's OTC Core Could Expand To Include National Brands
A Safe Harbor For Biotechs? Ascletis, BeiGene Mark Early Wins For HK Exchange
Novartis Pushes Dermatology Momentum By Licensing Atopic Dermatitis MAb
Hong Kong Ushers in 'New Era' For Bioventures As Listing Rules Eased

Topics

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV123585

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel